Osanni Bio
Latest round
- Series B
Last raised
- Jun 2026
Total raised
- $190M
Investors
- 4
About Osanni Bio
Osanni Bio, Inc. is a US-based biotechnology firm specializing in the development of innovative therapeutic medicines, particularly within ophthalmology and cardiology, aimed at addressing critical unmet medical needs. Founded in 2022 and headquartered in San Francisco, US, Osanni Bio, Inc. focuses on transformative therapies for various diseases.D. is the founder and Chief Executive Officer (CEO) of Osanni Bio, a development-stage therapeutics platform focused on discovering and developing innovative medicines. Osanni Bio specializes in the discovery and development of transformative therapeutic medicines, with a strong focus on ophthalmology and cardiology. The company's core offerings stem from an innovative approach that integrates biodesign principles, advanced technology, and capital efficiency to address significant unmet medical needs. Osanni's products are designed to provide novel solutions for various diseases, particularly in areas where traditional therapies have proven inadequate.Osanni Bio's revenue model is primarily based on the successful advancement of its therapeutic programs and subsequent commercialization through its affiliate companies. The company engages in strategic partnerships to enhance its product offerings, which could include collaborations with healthcare providers and pharmaceutical distributors. Transactions within this framework may involve direct sales of developed therapeutics to healthcare facilities or agreements that facilitate the distribution of their products through established medical supply chains. The structure of these transactions generally aligns with B2B relationships, where Osanni Bio works closely with industry partners to ensure that its innovative medicines reach the end users efficiently.Osanni Bio is focused on advancing the development of its therapeutic programs, with ongoing designs for new products targeted for launch in the coming years. The company has plans to expand into both North American and European markets to increase patient access to its innovative therapies.
Who invested in Osanni Bio
4 investors across 1 round
See all investors in Osanni Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 23, 2026
Amount
$190M
Investors
Questions about Osanni Bio
Who invested in Osanni Bio?
Osanni Bio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Osanni Bio raised?
Osanni Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Osanni Bio last raise money?
Osanni Bio's most recent round on record is a Series B, in Jun 2026.
What does Osanni Bio do?
Osanni Bio is a biotechnology company.
Where is Osanni Bio headquartered?
Osanni Bio is headquartered in San Francisco, US.
Which VCs invest in companies like Osanni Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Osanni Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Osanni Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.